Asia Pacific Autoimmune Disease Therapeutics Market (2019-2025)
The Asia Pacific Autoimmune Disease Therapeutics Market would witness market growth of 5.72% CAGR during the forecast period (2019–2025).
Autoimmune diseases can be understood as disorders in which the immune system erroneously attacks the patient's body. In the usual scenario, however, the immune system protects against germs such as bacteria and viruses by sending out an army of fighter cells to attack them when it senses these foreign invaders.
Asia-Pacific offers profitable expansion opportunities for main players working on the therapeutic market for autoimmune disease due to the large population base, increased buying power, increased autoimmune disease incidence, and increased demand for advanced autoimmune disease therapeutics. Growth in the number of aging populations and increased early detection of the disease with increased healthcare spending are anticipated to boost growth in this region's market for autoimmune disease therapeutics.
Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis.
Scope of the Study
Market Segmentation:
By Indication
Autoimmune diseases can be understood as disorders in which the immune system erroneously attacks the patient's body. In the usual scenario, however, the immune system protects against germs such as bacteria and viruses by sending out an army of fighter cells to attack them when it senses these foreign invaders.
Asia-Pacific offers profitable expansion opportunities for main players working on the therapeutic market for autoimmune disease due to the large population base, increased buying power, increased autoimmune disease incidence, and increased demand for advanced autoimmune disease therapeutics. Growth in the number of aging populations and increased early detection of the disease with increased healthcare spending are anticipated to boost growth in this region's market for autoimmune disease therapeutics.
Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis.
Scope of the Study
Market Segmentation:
By Indication
- Rheumatic Disease
- Diabetes
- Multiple Sclerosis
- Inflammatory Bowel Disease
- Other Indications
- Anti-Inflammatory
- Anti-Hyperglycemics
- NSAIDs
- Interferons
- Other Drugs
- Hospital Pharmacy
- Online
- Retail Pharmacies and Drug Stores
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- ABBOTT Laboratories
- Bio-Rad Laboratories, Inc.
- Johnson and Johnson
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Merck & Co., Inc.
- Bayer AG
- AbbVie, Inc.
- Amgen, Inc.
- Novartis AG
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Indication
1.4.2 Asia Pacific Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 Asia Pacific Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 Asia Pacific Autoimmune Disease Therapeutics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION
3.1 Asia Pacific Rheumatic Disease Market by Country
3.2 Asia Pacific Diabetes Market by Country
3.3 Asia Pacific Multiple Sclerosis Market by Country
3.4 Asia Pacific Inflammatory Bowel Disease Market by Country
3.5 Asia Pacific Other Indications Market by Country
CHAPTER 4. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS
4.1 Asia Pacific Anti-Inflammatory Market by Country
4.2 Asia Pacific Anti-Hyperglycemics Market by Country
4.3 Asia Pacific NSAIDs Market by Country
4.4 Asia Pacific Interferons Market by Country
4.5 Asia Pacific Other Drugs Market by Country
CHAPTER 5. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL
5.1 Asia Pacific Hospital Pharmacy Market by Country
5.2 Asia Pacific Online Market by Country
5.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country
CHAPTER 6. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
6.1 China Autoimmune Disease Therapeutics Market
6.1.1 China Autoimmune Disease Therapeutics Market by Indication
6.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
6.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 Japan Autoimmune Disease Therapeutics Market
6.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
6.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
6.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 India Autoimmune Disease Therapeutics Market
6.3.1 India Autoimmune Disease Therapeutics Market by Indication
6.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
6.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 South Korea Autoimmune Disease Therapeutics Market
6.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
6.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
6.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
6.5 Singapore Autoimmune Disease Therapeutics Market
6.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
6.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
6.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
6.6 Malaysia Autoimmune Disease Therapeutics Market
6.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
6.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
6.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
6.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
6.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
6.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
6.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
CHAPTER 7. COMPANY PROFILES
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Indication
1.4.2 Asia Pacific Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 Asia Pacific Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 Asia Pacific Autoimmune Disease Therapeutics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION
3.1 Asia Pacific Rheumatic Disease Market by Country
3.2 Asia Pacific Diabetes Market by Country
3.3 Asia Pacific Multiple Sclerosis Market by Country
3.4 Asia Pacific Inflammatory Bowel Disease Market by Country
3.5 Asia Pacific Other Indications Market by Country
CHAPTER 4. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS
4.1 Asia Pacific Anti-Inflammatory Market by Country
4.2 Asia Pacific Anti-Hyperglycemics Market by Country
4.3 Asia Pacific NSAIDs Market by Country
4.4 Asia Pacific Interferons Market by Country
4.5 Asia Pacific Other Drugs Market by Country
CHAPTER 5. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL
5.1 Asia Pacific Hospital Pharmacy Market by Country
5.2 Asia Pacific Online Market by Country
5.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country
CHAPTER 6. ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY
6.1 China Autoimmune Disease Therapeutics Market
6.1.1 China Autoimmune Disease Therapeutics Market by Indication
6.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
6.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 Japan Autoimmune Disease Therapeutics Market
6.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
6.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
6.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 India Autoimmune Disease Therapeutics Market
6.3.1 India Autoimmune Disease Therapeutics Market by Indication
6.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
6.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 South Korea Autoimmune Disease Therapeutics Market
6.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
6.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
6.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
6.5 Singapore Autoimmune Disease Therapeutics Market
6.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
6.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
6.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
6.6 Malaysia Autoimmune Disease Therapeutics Market
6.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
6.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
6.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
6.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
6.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
6.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
6.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
CHAPTER 7. COMPANY PROFILES
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements:
LIST OF TABLES
TABLE 1 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 40 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 41 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 42 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 43 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 44 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 45 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 46 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 47 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 48 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 49 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 50 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 51 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 56 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 57 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 58 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 59 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 60 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 61 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 62 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 69 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 70 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 71 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 72 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 77 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 78 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 79 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 80 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 81 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 82 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 95 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 96 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 97 KEY INFORMATION – PFIZER, INC.
TABLE 98 KEY INFORMATION – MERCK & CO., INC.
TABLE 99 KEY INFORMATION – BAYER AG
TABLE 100 KEY INFORMATION – ABBVIE, INC.
TABLE 101 KEY INFORMATION – AMGEN, INC.
TABLE 102 KEY INFORMATION – NOVARTIS AG
TABLE 1 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 40 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 41 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 42 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 43 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 44 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 45 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 46 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 47 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 48 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 49 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 50 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 51 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 52 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 53 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 56 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 57 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 58 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 59 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 60 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 61 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 62 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 69 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 70 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 71 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 72 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 77 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 78 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 79 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 80 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 81 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 82 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 94 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 95 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 96 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 97 KEY INFORMATION – PFIZER, INC.
TABLE 98 KEY INFORMATION – MERCK & CO., INC.
TABLE 99 KEY INFORMATION – BAYER AG
TABLE 100 KEY INFORMATION – ABBVIE, INC.
TABLE 101 KEY INFORMATION – AMGEN, INC.
TABLE 102 KEY INFORMATION – NOVARTIS AG
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
